DUBLIN (AP) — DUBLIN (AP) — Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $7.7 million in its third quarter.
On a per-share basis, the Dublin-based company said it had a loss of 2 cents. Earnings, adjusted for restructuring costs and stock option expense, were 1 cent per share.
The biopharmaceutical company posted revenue of $49.7 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $43.2 million.
Amarin shares have climbed 95% since the beginning of the year. The stock has risen 49% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
